Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Mitochondrial DNA. Part B, Resources|December 3, 2025
The complete chloroplast genome sequence of <i>Pothos chinensis</i> (Raf.) MerrQiaomei Cai, Xianglan Liang, Lichai Yuan, et al.International Journal of Biological Macromolecules|April 4, 2025
STEAP Proteins: Roles in disease biology and potential for therapeutic interventionQiaomei Cai, Chao Jing, Xudong Wang, et al.Science Signaling|January 9, 2024
The aldehyde dehydrogenase ALDH1B1 exerts antiviral effects through the aggregation of the adaptor MAVSNina Sun, Qiaomei Cai, Yurui Zhang, et al.Frontiers in Immunology|June 25, 2025
CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapyYu Chen, Wancheng Liu, Qiaomei Cai, et al.Cancer Immunology Research|February 19, 2022
CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous RetrovirusesYu Chen, Qiaomei Cai, Chaohu Pan, et al.Cellular & Molecular Immunology|November 16, 2021
Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagensWancheng Liu, Meiling Gao, Lili Li, et al.Cell & Bioscience|February 17, 2024
Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusionQiaomei Cai, Nina Sun, Yurui Zhang, et al.Journal of Medical Virology|January 3, 2023
SERTAD3 induces proteasomal degradation of ZIKV capsid protein and represents a therapeutic targetNina Sun, Rong-Rong Zhang, Guang-Yuan Song, et al.Cellular & Molecular Immunology|January 5, 2022
Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1Chaohu Pan, Qiaomei Cai, Xiaorong Li, et al.Journal of Hepatology|October 18, 2025
HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responsesHongfeng Yuan, Lina Zhao, Guang Yang, et al.Pageof 1